Latest market price
0.35
-0.03-8.32%
OverviewShort InterestFilings
EYPTQT31EyePoint Pharmaceuticals, Inc.·NASDAQ
0.35-8.32%

Latest SEC Filings

Form category
DescriptionFilingDocument
Oct 30, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Oct 27, 2026SC 13GBeneficial ownership statement (passive)
Oct 19, 20268-KCurrent report
Oct 19, 20268-KCurrent report
Oct 07, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Sep 10, 20268-KCurrent report
Sep 08, 2026SC 13GBeneficial ownership statement (passive)
Aug 24, 20264Statement of changes in beneficial ownership
Aug 18, 20264Statement of changes in beneficial ownership
Aug 17, 20268-KCurrent report
Aug 14, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Aug 12, 2026SC 13GBeneficial ownership statement (passive)
Aug 05, 20268-KCurrent report
Aug 05, 2026S-8Registration of employee benefit securities
Aug 05, 202610-QQuarterly report
Jul 31, 2026SC 13GBeneficial ownership statement (passive)
Jul 30, 20268-KCurrent report
Jul 28, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Jul 17, 20268-KCurrent report
Jul 14, 20264Statement of changes in beneficial ownership
Jul 02, 20264Statement of changes in beneficial ownership
Jun 22, 20268-KCurrent report
May 27, 20264Statement of changes in beneficial ownership
May 15, 2026SC 13G/ABeneficial ownership statement (passive, amended)
May 14, 20268-KCurrent report
#1 / 25 of 436
Page
▼
/ 18